Most a short while ago, it's been discovered that conolidine and the above mentioned derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in comparable locations as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors, this receptor functions for a scavenger and won't act